See more : FTAI Infrastructure Inc. (FIP) Income Statement Analysis – Financial Results
Complete financial analysis of DaVita Inc. (DVA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of DaVita Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Modiv Inc. (MDV) Income Statement Analysis – Financial Results
- Spiffbet AB (SPIFF.ST) Income Statement Analysis – Financial Results
- Zhejiang Hailide New Material Co.,Ltd (002206.SZ) Income Statement Analysis – Financial Results
- Green Scientific Labs Holdings Inc. (GSL.CN) Income Statement Analysis – Financial Results
- Zhenro Properties Group Limited (6158.HK) Income Statement Analysis – Financial Results
DaVita Inc. (DVA)
About DaVita Inc.
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12.14B | 11.61B | 11.62B | 11.55B | 11.39B | 11.40B | 10.88B | 14.75B | 13.78B | 12.80B | 11.76B | 8.19B | 6.79B | 6.45B | 6.11B | 5.66B | 5.26B | 4.88B | 2.97B | 2.30B | 2.05B | 1.85B | 1.65B | 1.49B | 1.45B | 1.20B | 438.20M | 272.90M | 89.70M | 99.00M |
| Cost of Revenue | 8.32B | 8.21B | 7.97B | 7.99B | 7.91B | 8.20B | 7.64B | 10.65B | 9.82B | 9.12B | 8.20B | 5.58B | 4.68B | 4.47B | 4.25B | 3.92B | 3.59B | 3.39B | 2.04B | 1.56B | 1.36B | 1.22B | 1.10B | 1.03B | 993.24M | 772.70M | 292.50M | 184.00M | 57.40M | 65.60M |
| Gross Profit | 3.82B | 3.40B | 3.65B | 3.56B | 3.47B | 3.21B | 3.24B | 4.10B | 3.96B | 3.68B | 3.57B | 2.61B | 2.11B | 1.97B | 1.86B | 1.74B | 1.67B | 1.49B | 938.68M | 743.53M | 685.86M | 636.95M | 550.10M | 454.15M | 452.11M | 432.20M | 145.70M | 88.90M | 32.30M | 33.40M |
| Gross Profit Ratio | 31.47% | 29.29% | 31.38% | 30.84% | 30.50% | 28.14% | 29.76% | 27.79% | 28.71% | 28.73% | 30.31% | 31.85% | 31.08% | 30.60% | 30.45% | 30.74% | 31.80% | 30.54% | 31.56% | 32.35% | 33.52% | 34.34% | 33.32% | 30.56% | 31.28% | 35.87% | 33.25% | 32.58% | 36.01% | 33.74% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.47B | 1.36B | 1.20B | 1.25B | 1.10B | 1.14B | 1.06B | 1.59B | 1.45B | 1.26B | 1.18B | 894.58M | 691.24M | 579.00M | 531.53M | 654.47M | 627.92M | 579.72M | 334.38M | 233.04M | 195.33M | 181.33M | 126.90M | 163.27M | 263.81M | 120.20M | 38.70M | 24.80M | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.47B | 1.36B | 1.20B | 1.25B | 1.10B | 1.14B | 1.06B | 1.59B | 1.45B | 1.26B | 1.18B | 894.58M | 691.24M | 579.00M | 531.53M | 654.47M | 627.92M | 579.72M | 334.38M | 233.04M | 195.33M | 181.33M | 126.90M | 163.27M | 263.81M | 120.20M | 38.70M | 24.80M | 9.40M | 11.50M |
| Other Expenses | 743.66M | 732.60M | 680.62M | 630.44M | 615.15M | 583.74M | 17.67M | 8.73M | 8.89M | 2.37M | 4.79M | 3.74M | 455.42M | 396.63M | 388.33M | 263.45M | 183.68M | 171.16M | 138.93M | 100.36M | 112.00M | 64.29M | 105.21M | 111.61M | 112.48M | 92.00M | 27.10M | 15.40M | 4.40M | 0.00 |
| Operating Expenses | 2.22B | 2.09B | 1.88B | 1.88B | 1.72B | 1.72B | 1.62B | 2.32B | 2.59B | 1.88B | 2.11B | 1.33B | 956.43M | 975.63M | 919.86M | 917.92M | 811.60M | 750.88M | 473.30M | 333.40M | 307.33M | 245.62M | 232.11M | 274.88M | 376.29M | 212.20M | 65.80M | 40.20M | 13.80M | 16.20M |
| Cost & Expenses | 10.54B | 10.30B | 9.85B | 9.87B | 9.63B | 9.91B | 9.26B | 12.97B | 12.42B | 11.00B | 10.31B | 6.91B | 5.64B | 5.45B | 5.17B | 4.84B | 4.40B | 4.14B | 2.51B | 1.89B | 1.67B | 1.46B | 1.33B | 1.31B | 1.37B | 984.90M | 358.30M | 224.20M | 71.20M | 81.80M |
| Interest Income | 0.00 | 368.75M | 279.75M | 297.03M | 435.23M | 0.00 | 0.00 | 0.00 | 0.00 | 17.41M | 0.00 | 288.53M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 398.55M | 357.02M | 285.25M | 304.11M | 443.82M | 487.44M | 430.63M | 414.38M | 405.94M | 410.29M | 429.94M | 0.00 | 241.09M | 255.99M | 185.76M | 199.89M | 156.95M | 489.02M | 107.74M | 44.07M | 113.71M | 98.33M | 71.43M | 149.58M | 399.35M | 256.00M | 15.40M | 14.40M | 4.10M | 0.00 |
| Depreciation & Amortization | 745.44M | 732.60M | 680.62M | 630.44M | 615.15M | 591.04M | 559.91M | 509.50M | 638.02M | 590.94M | 528.12M | 343.91M | 267.32M | 234.38M | 228.99M | 216.92M | 193.47M | 173.30M | 119.72M | 86.67M | 74.69M | 64.67M | 105.21M | 111.61M | 112.48M | 92.00M | 27.10M | 15.40M | 4.40M | 4.70M |
| EBITDA | 2.35B | 2.05B | 2.45B | 2.31B | 2.37B | 2.08B | 2.38B | 2.55B | 1.77B | 2.43B | 2.10B | 1.63B | 1.43B | 1.23B | 1.16B | 1.03B | 1.06B | 912.73M | 465.37M | 467.79M | 434.62M | 448.49M | 416.07M | 290.88M | 188.30M | 303.40M | 165.20M | 105.70M | 33.20M | 21.90M |
| EBITDA Ratio | 19.33% | 17.71% | 21.38% | 20.42% | 21.19% | 18.30% | 22.12% | 17.06% | 14.37% | 18.06% | 17.23% | 19.96% | 20.94% | 19.10% | 19.14% | 18.13% | 18.58% | 23.33% | 19.50% | 21.43% | 23.29% | 24.25% | 25.36% | 20.36% | 22.83% | 31.98% | 23.87% | 22.79% | 24.75% | 22.12% |
| Operating Income | 1.60B | 1.34B | 1.80B | 1.69B | 1.64B | 1.53B | 1.81B | 1.89B | 1.17B | 1.82B | 1.55B | 1.30B | 1.13B | 997.03M | 940.27M | 821.77M | 862.21M | 739.43M | 465.37M | 410.12M | 378.54M | 391.33M | 317.99M | 179.27M | 75.82M | 220.00M | 79.90M | 48.70M | 18.50M | 17.20M |
| Operating Income Ratio | 13.20% | 11.53% | 15.47% | 14.67% | 14.43% | 13.38% | 16.67% | 12.85% | 8.49% | 14.19% | 13.18% | 15.84% | 16.65% | 15.46% | 15.39% | 14.52% | 16.38% | 15.15% | 15.65% | 17.84% | 18.50% | 21.10% | 19.26% | 12.06% | 5.25% | 18.26% | 18.23% | 17.85% | 20.62% | 17.37% |
| Total Other Income/Expenses | -425.69M | -372.78M | -278.88M | -376.37M | -447.88M | -477.35M | -412.97M | -406.61M | -413.63M | -505.47M | -425.16M | -295.78M | -238.11M | -252.57M | -182.05M | -164.97M | -234.69M | -263.67M | -134.27M | -19.24M | -71.67M | -67.64M | -68.29M | -134.34M | -257.65M | -164.40M | 1.30M | 8.70M | -3.60M | -8.80M |
| Income Before Tax | 1.18B | 966.28M | 1.52B | 1.32B | 1.20B | 1.05B | 1.40B | 1.49B | 723.14M | 1.31B | 1.12B | 1.00B | 892.67M | 744.46M | 758.22M | 609.46M | 627.52M | 475.76M | 331.10M | 361.88M | 288.27M | 316.19M | 240.94M | 44.94M | -181.83M | 56.90M | 62.10M | 40.10M | 11.10M | 8.40M |
| Income Before Tax Ratio | 9.70% | 8.32% | 13.07% | 11.41% | 10.50% | 9.19% | 12.87% | 10.10% | 5.25% | 10.24% | 9.56% | 12.23% | 13.14% | 11.55% | 12.41% | 10.77% | 11.92% | 9.75% | 11.13% | 15.74% | 14.09% | 17.05% | 14.60% | 3.02% | -12.58% | 4.72% | 14.17% | 14.69% | 12.37% | 8.48% |
| Income Tax Expense | 220.12M | 198.09M | 306.73M | 313.93M | 279.63M | 258.40M | 323.86M | 455.81M | 295.73M | 446.34M | 381.01M | 359.85M | 315.74M | 260.24M | 278.47M | 235.30M | 245.74M | 186.43M | 123.68M | 139.63M | 112.48M | 129.50M | 104.60M | 27.96M | -34.57M | 41.60M | 25.10M | 16.40M | 4.60M | 3.50M |
| Net Income | 691.54M | 768.19M | 978.45M | 773.64M | 810.98M | 790.08M | 663.62M | 879.87M | 269.73M | 723.11M | 633.45M | 536.02M | 478.00M | 405.68M | 422.68M | 374.16M | 381.78M | 289.69M | 228.64M | 222.25M | 175.79M | 157.33M | 137.32M | 13.49M | -147.26M | -4.30M | 37.00M | 16.00M | 9.10M | 4.90M |
| Net Income Ratio | 5.70% | 6.62% | 8.42% | 6.70% | 7.12% | 6.93% | 6.10% | 5.97% | 1.96% | 5.65% | 5.38% | 6.55% | 7.04% | 6.29% | 6.92% | 6.61% | 7.25% | 5.94% | 7.69% | 9.67% | 8.59% | 8.48% | 8.32% | 0.91% | -10.19% | -0.36% | 8.44% | 5.86% | 10.14% | 4.95% |
| EPS | 7.62 | 8.26 | 9.30 | 6.54 | 5.29 | 4.63 | 3.52 | 4.36 | 1.27 | 3.41 | 3.02 | 2.79 | 2.52 | 2.00 | 2.04 | 1.78 | 1.80 | 1.40 | 1.13 | 1.13 | 0.93 | 0.73 | 0.55 | 0.06 | -0.60 | -0.02 | 0.24 | 0.14 | 0.08 | 0.09 |
| EPS Diluted | 7.42 | 8.02 | 8.90 | 6.39 | 5.27 | 4.58 | 3.47 | 4.29 | 1.25 | 3.33 | 2.95 | 2.74 | 2.48 | 1.97 | 2.03 | 1.77 | 1.78 | 1.37 | 1.10 | 1.08 | 0.77 | 0.58 | 0.49 | 0.05 | -0.60 | -0.02 | 0.24 | 0.13 | 0.08 | 0.08 |
| Weighted Avg Shares Out | 90.79M | 92.99M | 105.23M | 119.80M | 153.18M | 170.79M | 188.63M | 201.64M | 211.87M | 212.30M | 209.94M | 192.04M | 189.32M | 203.01M | 207.21M | 210.30M | 211.79M | 207.04M | 201.52M | 197.45M | 188.69M | 215.49M | 251.30M | 244.74M | 243.46M | 240.43M | 155.05M | 114.73M | 111.48M | 54.42M |
| Weighted Avg Shares Out (Dil) | 93.18M | 95.83M | 109.95M | 122.62M | 153.81M | 172.36M | 191.35M | 204.90M | 216.25M | 216.93M | 214.76M | 195.94M | 193.06M | 206.12M | 208.34M | 211.88M | 214.84M | 211.59M | 208.14M | 205.72M | 227.52M | 271.44M | 278.82M | 249.47M | 243.46M | 245.10M | 155.05M | 119.94M | 111.48M | 61.22M |
DaVita Inc. (DVA) Hit a 52 Week High, Can the Run Continue?
DaVita HealthCare (DVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Are Investors Undervaluing DaVita (DVA) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong...
DaVita Opens its Doors to Anyone in Florida Needing Dialysis After Hurricane Milton
TAMPA, Fla. , Oct. 11, 2024 /PRNewswire/ -- Following the widespread impact of Hurricane Milton, DaVita Kidney Care dialysis centers have opened their doors to anyone in Florida needing treatment, including those who normally treat at other providers.
DaVita Inc. Schedules 3rd Quarter 2024 Investor Conference Call
DENVER , Oct. 9, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Tuesday, October 29, 2024, at 5:00 p.m. Eastern Time.
DaVita Stock Gains 47.3% Year to Date: What's Behind the Rally?
DVA's strong performance and growth strategies, including patient-centric care and international expansion, position it well for continued success despite potential risks.
DaVita Prepares Thousands of Dialysis Patients for Hurricane Milton
TAMPA , Oct. 8, 2024 /PRNewswire/ -- DaVita Kidney Care , a leading provider of kidney care services, has activated its emergency response plan in preparation for Hurricane Milton's landfall in Florida. DaVita's emergency response plans focus on proactively dialyzing...
Here's Why You Should Add DaVita Stock to Your Portfolio Now
DVA's strength in its kidney care business raises optimism about the stock.
Why DaVita HealthCare (DVA) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
5 Stocks Trading Near 52-Week High With Room to Rise Further
Investors target stocks that have been on a bullish run lately. Stocks like THC, SLVM, DVA, NCLH and IAG are seeing price strength, and the momentum is likely to continue.
Source: https://incomestatements.info
Category: Stock Reports